Our Protein-Oligonucleotide Conjugation services support biotech companies, diagnostic developers, pharmaceutical research teams, and academic groups that need well-defined protein-DNA or protein-RNA constructs for advanced assay development, imaging, biosensing, barcoding, and delivery-oriented research. By combining the recognition, catalytic, or targeting properties of proteins with the programmability of oligonucleotides, these conjugates can serve as powerful tools for immuno-PCR, proximity assays, multiplexed imaging, single-cell workflows, capture systems, and DNA-directed assembly.
Successful protein-oligonucleotide conjugation requires more than linking two biomolecules together. Protein class, oligonucleotide format, reactive handle placement, linker architecture, loading ratio, buffer composition, purification route, and analytical strategy all affect whether the final construct remains soluble, functionally active, and assay-ready. Our platform integrates custom oligonucleotide preparation, protein activation, conjugation route selection, purification, and fit-for-purpose characterization to help teams move from concept to reproducible research materials with lower technical risk.
Protein Activity Loss: Many conjugation projects fail because reactive chemistry is introduced without enough control over the attachment site. Random lysine labeling can compromise antigen recognition, catalytic function, or protein-protein interactions. We help clients choose between random, semi-controlled, and site-selective strategies based on the protein format, the acceptable degree of heterogeneity, and the intended downstream assay.
Uncontrolled Oligo Loading: The number of oligonucleotides attached per protein directly affects conjugate behavior. Too little loading can reduce signal or hybridization efficiency, while too much loading can increase steric hindrance, aggregation, or nonspecific binding. We design reaction conditions and purification workflows around realistic oligo-to-protein ratio targets for the specific construct type.
Linker and Spacer Mismatch: Even when coupling chemistry works, the conjugate may still underperform if the oligonucleotide is too close to the protein surface, if the linker is too hydrophobic, or if the spacer length is poorly matched to the readout format. We review linker chemistry, spacer length, flexibility, and cargo orientation so the oligonucleotide remains accessible for hybridization or barcode recognition.
Difficult Reaction Cleanup: Protein-oligonucleotide reactions often produce mixtures containing free oligonucleotide, unconjugated protein, linker-derived byproducts, and higher-order aggregates. These impurities can distort assay results and make loading estimates unreliable. Our service plans include cleanup strategies such as desalting, size-based separation, ion-exchange workflows, and orthogonal polishing where required.
Analytics Across Two Molecular Classes: Protein-oligonucleotide conjugates sit at the interface of bioconjugation and oligonucleotide chemistry, so conventional protein QC or oligo QC alone is not enough. We build analytical packages that address identity, oligo loading, free-species carryover, aggregation, and application fit using methods selected for the actual construct, not a one-size-fits-all panel.
Starting Material Compatibility: Client-supplied antibodies, enzymes, recombinant proteins, DNA barcodes, RNA oligos, ASOs, or siRNA cargoes often arrive in buffers or formats that are not directly compatible with coupling chemistry. We evaluate upstream material quality, exchange into workable conditions, and define practical acceptance criteria before process execution begins.
Our services are designed for teams that need more than a simple coupling reaction. We support the full workflow from construct planning through purified conjugate delivery, with options for antibodies, antibody fragments, enzymes, carrier proteins, affinity proteins, tagged recombinant proteins, and custom oligonucleotide payloads.
Depending on project needs, we can work with client-supplied starting materials or build the oligonucleotide component through our internal oligonucleotide synthesis services and modification workflows so that the final conjugate is aligned with the intended research readout.
Different proteins, oligonucleotide formats, and research goals require different coupling strategies. The table below helps teams compare common project types, suitable starting materials, preferred conjugation routes, and the main technical tradeoffs that should be considered before execution.
| Project Format | Typical Starting Materials | Preferred Oligo Handle or Format | Common Conjugation Routes | Main Advantages | Primary Watchouts |
| Antibody Barcodes | Native IgG, purified monoclonal antibody, secondary antibody | ssDNA barcode, short docking strand, amplified detection tag | Lysine coupling, cysteine-directed coupling, glycan- or tag-enabled site-selective strategies | Supports immuno-PCR, proximity assays, and multiplexed protein detection | Random labeling can reduce binding, increase heterogeneity, and elevate background |
| Small Affinity Probes | Fab fragments, nanobodies, affibodies, engineered binders | Short DNA strand, imaging barcode, hybridization handle | Site-selective cysteine chemistry, tag-mediated coupling, bioorthogonal click routes | Lower steric burden and shorter probe-to-target distance | Attachment site and oligo length strongly affect binding and assay geometry |
| Enzyme Conjugates | Reporter enzymes, ligases, polymerase-associated proteins, catalytic proteins | ssDNA, dsDNA, barcode oligo, functional RNA where applicable | Amine coupling, thiol chemistry, engineered-tag conjugation | Useful for signal amplification, biosensing, and programmed assembly | Active-site disruption, buffer incompatibility, and aggregate formation must be controlled |
| Capture Systems | Streptavidin-class proteins, avidin derivatives, capture proteins, immobilization partners | Biotinylated oligo, spacer-linked capture strand, surface-ready barcode | Affinity assembly or covalent backup strategies | Fast route for target capture, bead loading, and chip-based workflows | Stoichiometry, reversible interactions, and surface crowding can affect assay reproducibility |
| Delivery Research Constructs | Albumin, targeting ligands, receptor-binding proteins, uptake-enabling proteins | ASO, siRNA-related strands, modified DNA/RNA cargoes | Site-selective coupling, controlled random coupling, cleavable or non-cleavable linker strategies | Supports receptor-targeting and intracellular delivery feasibility studies | Conjugate size, cargo accessibility, and stability can change uptake behavior |
| Tagged Recombinant Proteins | SNAP-tag, HaloTag, sortase-compatible, or other engineered proteins | Functionalized DNA/RNA with matching reactive tag or substrate | Enzymatic or self-labeling site-specific conjugation | Offers defined attachment sites and improved batch consistency | Requires compatible construct design and tag-aware upstream preparation |
Protein-oligonucleotide conjugates require a blended analytical strategy because the critical quality attributes come from both biomolecular components and from the linkage between them. This matrix summarizes the most common analytical questions, the reason they matter, and the methods typically considered during project release or troubleshooting.
| Quality Attribute | Why It Matters | Typical Methods | Common Output | Most Critical For |
| Component Identity | Confirms the intended protein and oligonucleotide inputs were incorporated into the final construct | UV/Vis review, gel methods, LC-based identity checks, MS-compatible workflows where suitable | Identity confirmation and material traceability summary | All conjugation projects |
| Oligo-to-Protein Ratio | Loading directly affects signal strength, hybridization accessibility, and biological behavior | UV deconvolution, LC-based distribution review, native or MS-enabled ratio analysis when feasible | Average loading or population distribution estimate | Antibody barcodes, enzyme conjugates, delivery-oriented constructs |
| Free Oligo Residuals | Residual unbound oligonucleotide can distort downstream assay signals and overstate performance | SEC, IEX, gel separation, fraction analysis | Cleanup effectiveness and residual free-species review | Immuno-PCR, PLA/PEA, imaging, capture assays |
| Free Protein Residuals | Unconjugated protein can create false negatives for ratio control and interfere with interpretation | SEC-HPLC, affinity cleanup review, electrophoretic separation | Conjugated versus unconjugated population profile | Controlled loading projects and purified reagent delivery |
| Aggregates and Fragments | Aggregation affects solubility, assay reproducibility, and storage stability | SEC-based analysis, gel methods, orthogonal LC workflows | High-molecular-weight and low-molecular-weight impurity trends | Antibodies, enzymes, multi-oligo loading formats |
| Attachment-Site Assessment | Helps explain functional loss, heterogeneity, or unexpected conjugate behavior | Subunit analysis, peptide mapping, MS-based site investigation where construct chemistry allows | Site localization or site-enrichment evidence | Site-selective antibody and recombinant protein programs |
| Application Fit | Chemical success alone does not guarantee assay performance | Binding review, hybridization checks, pilot assay testing, barcode or capture verification | Fit-for-use recommendation linked to the intended workflow | Imaging, biosensing, proximity assays, single-cell barcoding |
Our workflow is designed for research-stage construct development and purified conjugate delivery. Each stage is structured to reduce rework, clarify technical risks early, and generate data that help clients decide whether to progress directly to assay use, optimization, or a larger follow-on program.
We begin by defining the intended application, protein class, oligonucleotide format, desired loading range, acceptable heterogeneity, and expected deliverables. This stage turns a broad conjugation request into a workable construct plan tied to the actual assay or research objective.
Our team evaluates reactive handle placement, linker architecture, attachment-site logic, spacer requirements, and purification implications. We then recommend the most appropriate conjugation route based on the protein's structural sensitivity and the oligonucleotide's functional role.
Oligonucleotides are synthesized or checked for the required handles and purity, while proteins are reviewed for buffer compatibility, reactive site availability, and formulation constraints. Where necessary, we perform pre-conjugation processing such as handle introduction, buffer exchange, or reduction control.
The coupling reaction is carried out under defined conditions selected for the target construct. Reaction progress, over-labeling risk, and gross solubility behavior are monitored so that the project can stay aligned with the intended loading and functionality window.
The crude reaction mixture is cleaned up using fit-for-purpose purification steps to isolate the useful conjugate population. Analytical review then confirms key attributes such as component identity, loading behavior, free-species removal, aggregate profile, and other application-relevant parameters.
Final material is delivered with structured documentation describing the build strategy, purification outcome, and analytical observations. When clients are moving into immuno-PCR, imaging, barcoding, or biosensor studies, we can also provide practical recommendations for storage, reconstitution, and first-use handling.
Protein-oligonucleotide conjugation projects often fail when chemistry, purification, and assay logic are handled separately. Our service model is built to keep those decisions connected so that the final construct is not only chemically linked, but also more likely to function the way the project requires.
Protein-oligonucleotide conjugates are used across a wide range of modern research workflows because they connect selective protein recognition with nucleic-acid-driven amplification, hybridization, or barcoding. Our services are structured to support both established assay formats and custom platform development programs.
Whether you need an antibody barcode, an enzyme-linked oligonucleotide reagent, a site-selective affinity probe, or a broader protein-oligo development workflow, our team can help you build a construct that fits the intended research task. We support client programs from feasibility review through conjugation, purification, and analytical characterization, with attention to the real factors that determine whether the final conjugate performs in an assay or platform setting. Contact us to discuss your protein-oligonucleotide conjugation requirements and identify the most suitable chemistry, purification strategy, and analytical package for your project.
Protein-oligonucleotide conjugation is the process of attaching oligonucleotides (short DNA or RNA molecules) to proteins, such as antibodies or enzymes, to enhance their functionality. This conjugation is used in applications like drug delivery, diagnostics, and gene therapy.
Protein-oligonucleotide conjugation can be achieved through chemical, enzymatic, or hybridization-based methods. These approaches ensure stable binding between the oligonucleotide and the protein, enhancing the properties and applications of both molecules.
Challenges include achieving site-specific conjugation, maintaining the stability and activity of both the protein and oligonucleotide, and ensuring the purity of the conjugates. The synthesis and purification processes can be complex and time-consuming.
BOC Sciences offers a range of proteins for conjugation, including fluorescent proteins like GFP, RFP, and R-PE, as well as carrier proteins such as BSA and KLH. These proteins are chosen based on the specific application requirements.
Conjugation can be done through chemical reactions, where reactive groups on the oligonucleotides bind covalently to proteins. Enzymatic conjugation and hybridization-based methods are also employed depending on the specific project needs.
Loading ......
